Which ETFs hold Telix Pharmaceuticals Ltd (TLX)?
Australian biotech developing and selling radiopharmaceuticals for imaging and treating cancers.
24 Australian ETFs hold Telix Pharmaceuticals Ltd, a Health Care company from Australia. MVE has the biggest weighting at 1.18%. Across these funds, Australian ETF investors own about $117m of Telix Pharmaceuticals Ltd.
The ETFs with the most Telix Pharmaceuticals Ltd
All 24 ETFs that hold Telix Pharmaceuticals Ltd, ranked by weight
Best-endeavours estimate. Built from each issuer's published holdings, which may be weeks or months old, may cover only part of a fund (some publish only their top 10) and are matched by company name. Figures may be incomplete or inaccurate. Check the issuer's website and PDS before relying on them. General information only.
Weights from each issuer's published holdings (September to November 2026). Some funds list only their largest holdings. General information only, not a recommendation to buy or sell Telix Pharmaceuticals Ltd.
Common questions
Which ETF has the most Telix Pharmaceuticals Ltd?
MVE (VanEck S&P/ASX MidCap ETF) has the highest weighting, with 1.18% of the fund in Telix Pharmaceuticals Ltd.
What is the cheapest ETF that holds Telix Pharmaceuticals Ltd?
Of the ETFs where Telix Pharmaceuticals Ltd is at least 1% of the fund, MVE has the lowest fee at 0.45% a year, with 1.18% in Telix Pharmaceuticals Ltd.
How much Telix Pharmaceuticals Ltd do I own with $10,000 in VAS?
About $17. VAS is the largest ETF that holds Telix Pharmaceuticals Ltd, and Telix Pharmaceuticals Ltd makes up 0.17% of it.
How many Australian ETFs hold Telix Pharmaceuticals Ltd?
24 ETFs listed on the ASX or TMX Australia hold Telix Pharmaceuticals Ltd, based on issuers' published holdings.